Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Report Analyzes Trends in Laboratory Automation

By LabMedica International staff writers
Posted on 12 Mar 2013
The reduction of government reimbursement rates for laboratory tests and managed care cost-restraint measures has increased pressures for clinical labs to become more productive and cost efficient, according to a recent market report. More...
This is a key driver of the USD 10.4-billion-dollar lab automation sector, which includes systems for clinical and drug discovery labs.

However, the need to increase efficiency is hampered by the decreasing number of trained laboratory technologists and the expanding menu of diagnostic testing protocols. Frequently, increased efficiency means increasing or maintaining the timely output of test results with the same number or fewer technologists.

The report, published by healthcare market research publisher Kalorama Information (New York, NY, USA), explained that labs are not totally automating. When the trend toward clinical laboratory automation first began, in the early to mid-1990s, it was expected to include all lab functions—total laboratory automation (TLA). Targeted to the largest high volume laboratories, TLA requires a major financial commitment—in the millions—and the space for installing equipment. TLA is neither an affordable nor a practical solution for the majority of small to midsized hospital and other diagnostic laboratories. More recently, the trend for most clinical labs, and for many automation system manufacturers, has been toward modular automation, which includes independent work cells or self-contained workstations, and automation for transport, handling, and pre- and postanalytic processes.

In the US, only about 7% of the laboratories are considered able to benefit from TLA. A 500-bed hospital or smaller, for instance, is not suitable for TLA, unless it has a large outpatient business. A typical midsize to large lab in the US processes up to 3,000 tests per day. But with an aging population and the evolution of personalized medicine and molecular diagnostics, more labs are considering going total, according to the report.

“The best place to automate is at a lab’s preanalytical front end,” said Joe Constance, Kalorama Information analyst and author of the report, “minimizing those non-value-added steps, including such processes as sorting tubes, decapping, centrifugation, loading analyzers. Only a small number of labs are considered suitable for total automation, though each year that number gets larger. Usually, experts believe a laboratory should be performing at least one million to two million tests annually before installing a total system.”

According to Kalorama, labor accounts for more than 60% of the cost of producing test results. Automating a lab increases the available time for value-added steps, the tasks that technologists perform that help make a difference in the quality of the test, such as reviewing critical results.

Kalorama Information supplies independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices, and healthcare.

Related Links:
Kalorama Information



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.